CAS RN: 1672691-74-5

4-(4-Morpholinyl)-1,2,5-thiadiazol-3-yl N-cyclooctyl-N-methylcarbamate

Product Availability

Choose a grade to view its available package options.

13 package records11 with current stock3 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260512 1mg / 10mg / 25mg / 100mg / 250mg Out of stock 15 business days Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250409 100mg In stock Inquiry
Batchno.20260118 10mg In stock Inquiry
Batchno.20250919 25mg In stock Inquiry
Batchno.20250224 50mg In stock Inquiry
Batchno.20251122 5mg Out of stock Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260407 100mg In stock Shanghai Inquiry
Batchno.20260411 10mg In stock Shanghai Inquiry
Batchno.20260317 1mg In stock Shanghai Inquiry
Batchno.20251118 250mg In stock Shanghai Inquiry
Batchno.20250923 25mg In stock Shanghai Inquiry
Batchno.20251026 50mg In stock Shanghai Inquiry
Batchno.20251112 5mg In stock Shanghai Inquiry
  • Product code: starshine_CAS1672691-74-5
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1672691-74-5 / (4-morpholin-4-yl-1,2,5-thiadiazol-3-yl) N-cyclooctyl-N-methylcarbamate

Standard CAS: 1672691-74-5 Multi CAS: No

Basic Information

CAS
1672691-74-5
Multi CAS
No
Molecular Formula
C16H26N4O3S
Molecular Weight
354.500000
Exact Mass
354.172562
SMILES
CN(C1CCCCCCC1)C(=O)OC2=NSN=C2N3CCOCC3
InChI
InChI=1S/C16H26N4O3S/c1-19(13-7-5-3-2-4-6-8-13)16(21)23-15-14(17-24-18-15)20-9-11-22-12-10-20/h13H,2-12H2,1H3
InChIKey
WKSHMJCYWFOADB-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
24
Aromatic heavy atom count
5
Fraction Csp3
0.81
Rotatable bonds
3
H-bond acceptors
7
Molar refractivity
92.84
TPSA
67.79

LogP / Solubility

WLOGP
2.92
MLOGP
2.59
XLogP3
3.4
Consensus LogP
2.97
Log S (ESOL)
-3.83
Class (ESOL)
Poorly soluble
Log S (Ali)
-4.57
Class (Ali)
Slightly soluble
Log S (SILICOS-IT)
-4.75
Class (SILICOS-IT)
Slightly soluble

ADME

GI absorption
High
BBB permeant
Yes
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
No
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.81

Drug-likeness / Medicinal Chemistry

Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
2.5

Get In Touch

Contact Us